Home » Newsletters » BioWorld Science

BioWorld Science

May 6, 2005

View Archived Issues

Cannabinoid CB2 receptor: potential target for the treatment of atherosclerosis

In vitro results further support PPARdelta as a potential target for the treatment of diabetes

Apoptosis inducers act via TIP47, a novel target for anticancer therapy

Chugai develops an apoptosis-inducing antibody for multiple myeloma / News in context

CONRAD receives funding for phase III microbicide trials

Adams Respiratory Therapeutics licenses erdosteine for U.S.

Kos acquires rights to Biovail products in cardiovascular field

NsGene closes financing round

A new 5-HT4 receptor antagonist shows promise in the treatment of urinary incontinence

Researchers assess the benefits of VEGF gene therapy in coronary artery disease

Novartis highlights pharmaceutical research strategy

Therapeutic benefits found for alagebrium in older subjects with systolic hypertension

Diachrome reported to decrease cardiovascular risk in type 2 diabetics

Measurement of skin cholesterol levels may help estimate the risk of heart disease

Miikana licenses phase II anticancer compound from Roche

Orphan drug designation for Copernicus' DNA drug for cystic fibrosis

Fujirebio Diagnostics seeks approval of Mesomark mesothelioma test

Positive effects of CX-717 in human sleep deprivation study

Celator closes USD 40 million financing

BioVex submits IND for OncoVex(GM-CSF) in malignant melanoma

Orphan drug status for Lorus Therapeutics' GTI-2040 for AML

Abbott submits sNDA for more convenient tablet formulation for Kaletra

Peregrine submits Tarvacin IND for HCV

Predix' 5-HT2B receptor antagonist enters phase I for pulmonary hypertension

Requip approved for moderate to severe primary restless legs syndrome

Recent patents report new possible treatment options anxiety, depression, psychosis, etc.

Novel therapeutic agents for diabetes claimed in recent patents

Add-on aprepitant improves antiemetic therapy in breast cancer patients

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...